Trade Summary

6 months ago, Foresite Labs, LLC, serving as 10% owner at Alumis Inc. (ALMS), purchased 411,764 shares at $17.00 per share, for a total transaction value of $6,999,988.00. Following this transaction, Foresite Labs, LLC now holds 10,487,268 shares of ALMS.

This purchase represents a 4.00% increase in Foresite Labs, LLC's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, January 8, 2026 and publicly disclosed via SEC Form 4 filing on Monday, January 12, 2026 at 9:59 PM ET, 4 days after the trade was made.

Alumis Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.